Material Detail
Biomaterials and 3D Bioprinting Strategies to Model Glioblastoma and Blood-Brain Barrier
Glioblastoma (GBM) is a highly aggressive brain cancer with limited treatment options due to the blood-brain barrier. New 3D bioprinted models leveraging patient-derived cells and biomaterials provide a more reliable platform for studying the disease and testing potential treatments. These models mimic the physiological and pathological features of GBM and the blood-brain barrier, offering promise for more effective pre-clinical drug screenings...
Show MoreQuality
- User Rating
- Comments
- Learning Exercises
- Bookmark Collections
- Course ePortfolios
- Accessibility Info